Flucelvax
Quadrivalent 2019 - 2020 Flu Vaccine
60 mcg / 0.5 mL Indicated
For People 4 Years of Age and Above
Multiple Dose Vial 5 mL
Seqirus 70461041910

Flucelvax
Quadrivalent 2019 - 2020 Flu Vaccine
60 mcg / 0.5 mL Indicated
For People 4 Years of Age and Above
Multiple Dose Vial 5 mL
Seqirus 70461041910 , 70461-0419-10

This item could be sold only to specialists with valid related license .

Product Information NDC/Product#: 70461-0419-10 Description: Flucelvax® QIV 2019-20 MDV 10 Dose SEQI (Influenza Vaccine) Manufacturer: Seqirus USA, Inc. Drug Name: FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) Generic Name: INFLUENZA A VIRUS A/IDAHO /07/2018 (H1N1) ANTIGEN ( MDCK CELL DERIVED, PROPIO LACTONE INACTIVATED, INFL UENZA A VIRUS A/INDIANA/0 8/2018 (H3N2) ANTIGEN (MD CK CELL DERIVED, PROPIOLA CTONE INACTIVATED), INFLU ENZA B VIRUS B/SINGAPORE/ INFTT-16-0610/2016 ANTIGE N (MDCK CELL DERIVED, PRO PIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/IOWA/ 06/2017 ANTIGEN (MDCK CEL L DERIVED, PROPIOLACTONE INACTIVATED) FDA Drug Form: INJECTION, SUSPENSION FDA Route: INTRAMUSCULAR Labeler: Seqirus, Inc. Substance: INFLUENZA A VIRUS A/IDAHO /07/2018 (H1N1) ANTIGEN ( MDCK CELL DERIVED, PROPIO LACTONE INACTIVATED; INFL UENZA A VIRUS A/INDIANA/0 8/2018 (H3N2) ANTIGEN (MD CK CELL DERIVED, PROPIOLA CTONE INACTIVATED); INFLU ENZA B VIRUS B/SINGAPORE/ INFTT-16-0610/2016 ANTIGE N (MDCK CELL DERIVED, PRO PIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/IOWA/ 06/2017 ANTIGEN (MDCK CEL L DERIVED, PROPIOLACTONE INACTIVATED) FDA Strength: 15; 15; 15; 15 ug/.5mL; ug/.5mL; ug/.5mL ; ug/.5mL Packaging: 1 VIAL, MULTI-DOSE in 1 C ARTON (70461-419-10) > 5 mL in 1 VIAL, MULTI-DOSE (70461-419-11)